Hologic Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (23)

Latest Posts

About This Stock More About This Stock
Rayno Life Science Portfolio 2017
Article By: Rod Raynovich
Saturday, June 17, 2017 11:22 AM EST
Let's review Rayno Life Science Portfolio for 2017.
In this article: BMY, RHHBY, IBB, QQQ, AMGN, GILD, HOLX, XBI, ABBV, BLUE, FMI
Read
Hologic Beats Q1 Sales And EPS
Article By: Rod Raynovich
Wednesday, May 10, 2017 10:28 PM EST
Hologic's revenues Increased 3.2% and GAAP diluted Earnings Increased 666.7% Compared to Prior Year Period. The stock closed down 2% AH to $45.
In this article: RHHBY, HOLX, FMI
Read
Biotech In A Doldrums: Rallies Interrupted By Geopolitics, Trump Agenda And Flight To Safety
Article By: Rod Raynovich
Tuesday, April 11, 2017 7:38 PM EST
Recent geopolitical news has created a backdrop that has discouraged investors in biotech who were already risk averse from drug pricing issues. There has been little momentum over since mid-march with choppy sluggish trading.
In this article: RHHBY, IBB, ILMN, GILD, HOLX, VRTX, XBI, XLV, BLUE
Read
Four Consecutive Trading Sessions With Record Highs
Article By: Marvin R Clark
Tuesday, February 14, 2017 11:31 PM EST
Federal Reserve Chair Janet Yellen said the labor market is basically where the Fed wants it to be, and inflation is just a little lower than their target.
In this article: AET, AGN, CI, CS, FCX, GM, HUM, T, VZ, TOSBF, CYNO, HOLX, ZLTQ, TMUS, ANTM, QSR, PLKI, LITE
Read
Cynosure, Inc. To Be Acquired By Hologic, Inc. For $66/Share In Cash, Or $1.65 Bln
Article By: Lorimer Wilson
Tuesday, February 14, 2017 9:33 AM EST
Cynosure’s portfolio includes over 20 products across major categories, including non-invasive body contouring, hair removal, skin revitalization, and women’s health. Cynosure’s products are currently sold in over 130 countries.
In this article: CYNO, HOLX
Read

PARTNER HEADLINES

Latest Tweets for $HOLX

No tweets yet!